These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 23877061)

  • 1. Pathological ventricular remodeling: mechanisms: part 1 of 2.
    Burchfield JS; Xie M; Hill JA
    Circulation; 2013 Jul; 128(4):388-400. PubMed ID: 23877061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device.
    Segura AM; Frazier OH; Demirozu Z; Buja LM
    Cardiovasc Pathol; 2011; 20(3):139-45. PubMed ID: 20185339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte proliferation and ventricular remodeling.
    Leri A; Kajstura J; Anversa P
    J Card Fail; 2002 Dec; 8(6 Suppl):S518-25. PubMed ID: 12555168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in cardiac hypertrophic remodeling.
    Patrizio M; Marano G
    Ann Ist Super Sanita; 2016; 52(2):223-9. PubMed ID: 27364397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure.
    Nadal-Ginard B; Kajstura J; Leri A; Anversa P
    Circ Res; 2003 Feb; 92(2):139-50. PubMed ID: 12574141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets.
    Diwan A; Dorn GW
    Physiology (Bethesda); 2007 Feb; 22():56-64. PubMed ID: 17289931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocyte morphological characteristics differ between the phases of pulmonary hypertension-induced ventricular hypertrophy and failure.
    Minami S; Onodera T; Okazaki F; Miyazaki H; Ohsawa S; Mochizuki S
    Int Heart J; 2006 Jul; 47(4):629-37. PubMed ID: 16960417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of apoptosis in adverse ventricular remodeling.
    Abbate A; Narula J
    Heart Fail Clin; 2012 Jan; 8(1):79-86. PubMed ID: 22108728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
    Creemers EE; Pinto YM
    Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in cardiac remodeling and heart failure.
    Topkara VK; Mann DL
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):171-82. PubMed ID: 21431305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
    Frieler RA; Mortensen RM
    Circulation; 2015 Mar; 131(11):1019-30. PubMed ID: 25779542
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of cardiac remodeling by modulation of adrenergic receptors: a new frontier in heart failure.
    Perrino C; Rockman HA
    Curr Opin Cardiol; 2007 Sep; 22(5):443-9. PubMed ID: 17762546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
    Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
    J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into metabolic remodeling of the hypertrophic and failing myocardium.
    Hill BG; Schulze PC
    Circ Heart Fail; 2014 Nov; 7(6):874-6. PubMed ID: 25415956
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of left ventricular dilation remodeling with epicardial restraint devices in postmyocardial infarction heart failure.
    Topkara VK; Kondareddy S; Mann DL
    Curr Heart Fail Rep; 2009 Dec; 6(4):229-35. PubMed ID: 19948091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling.
    Zhao RR; Ackers-Johnson M; Stenzig J; Chen C; Ding T; Zhou Y; Wang P; Ng SL; Li PY; Teo G; Rudd PM; Fawcett JW; Foo RSY
    Circulation; 2018 Jun; 137(23):2497-2513. PubMed ID: 29371215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Notch pathway: a novel target for myocardial remodelling therapy?
    Ferrari R; Rizzo P
    Eur Heart J; 2014 Aug; 35(32):2140-5. PubMed ID: 24970336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.